Simon P. Fletcher

机构：Gilead Sciences (United States) · ORCID：0000-0003-1987-6179

发表论文 100 篇 · 总被引 4823 次 · h-index 36

代表论文

• An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression (2022 · Science Translational Medicine · 被引 114)
• Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure (2023 · Gut · 被引 84)
• High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response (2024 · Science Translational Medicine · 被引 66)
• Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression (2022 · Journal of Hepatology · 被引 66)
• Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection (2021 · JHEP Reports · 被引 53)
• Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro (2023 · Gut · 被引 42)